Topological properties of the drug targets regulated by microRNA in human protein-protein interaction network

Journal of Drug Targeting

Volumn 19, Issue 5, 2011, Pages 354-364

  Wang, Chenqu ^a   Jiang, Wei ^b   Li, Wei ^b   Lian, Baofeng ^b   Chen, Xiaowen ^b   Hua, Lin ^a   Lin, Hui ^a   Li, Dongguo ^a   Li, Xia ^a,b   Liu, Zhicheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Drug target; microRNA; protein protein interaction network; topological property

Indexed keywords

MICRORNA; PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG TARGETING; PRIORITY JOURNAL; PROBABILITY; PROTEIN DATABASE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTACTION NETWORK; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM;

DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG DISCOVERY; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEINS;

EID: 79955571592     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.504261     Document Type: Article

References (38)

1. Aittokallio T, Schwikowski B. (2006). Graph-based methods for analysing networks in cell biology. Brief Bioinformatics, 7, 243-255. (Pubitemid 44404874)
2. Ambros V. (2004). The functions of animal microRNAs. Nature, 431, 350-355. (Pubitemid 39265675)
3. Betel D, Wilson M, Gabow A, Marks DS, Sander C. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res, 36, D149-D153. (Pubitemid 351149712)
4. Borgatti SP, Everett MG. (2006). A Graph-theoretic perspective on centrality. Soc Netw, 28, 466-484. (Pubitemid 44089303)
5. Bu D, Zhao Y, Cai L, Xue H, Zhu X, Lu H, Zhang J, Sun S, Ling L, Zhang N, Li G, Chen R. (2003). Topological structure analysis of the protein-protein interaction network in budding yeast. Nucleic Acids Res, 31, 2443-2450. (Pubitemid 37442113)
6. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 102, 13944-13949. (Pubitemid 41377683)
7. Cusick ME, Klitgord N, Vidal M, Hill DE. (2005). Interactome: gateway into systems biology. Hum Mol Genet, 14(Spec No. 2), R171-R181. (Pubitemid 41631885)
8. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia, 21, 912-916. (Pubitemid 46672066)
9. Sonkolya E, Stáhlea M, Pivarcsi A. (2008). MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol, 18, 131-140.
10. Fraser HB, Hirsh AE, Steinmetz LM, Scharfe C, Feldman MW. (2002). Evolutionary rate in the protein interaction network. Science 296, 750-752. (Pubitemid 34442006)
11. Garofalo M, Condorelli G, Croce CM. (2008). MicroRNAs in diseases and drug response. Curr Opin Pharmacol, 8, 661-667
12. Kar G, Gursoy A, Keskin O. (2009). Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol, 5, e1000601.
13. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, Hall H, Timm S, Wang AG, Werge T. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE, 2, e873.
14. Hopkins AL. (2008). Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol, 4, 682-690.
15. Hsu CW, Juan HF, Huang HC. (2008). Characterization of microRNAregulated protein-protein interaction network. Proteomics, 8, 1975-1979.
16. Janssen JJ, Klaver SM, Waisfisz Q, Pasterkamp G, de Kleijn DP, Schuurhuis GJ, Ossenkoppele GJ. (2005). Identification of genes potentially involved in disease transformation of CML. Leukemia, 19, 998-1004. (Pubitemid 40862011)
17. Joy MP, Brock A, Ingber DE, Huang S. (2005). High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol, 2, 96-103. (Pubitemid 41627865)
18. Leicht, DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, Tzivion G. (2007). Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta, 1773, 1196-1212. (Pubitemid 47161035)
19. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ. (2007). miR- 181a is an intrinsic modulator of T cell sensitivity and selection. Cell, 129, 147-161. (Pubitemid 46507589)
20. Liang H, Li WH. (2007). MicroRNA regulation of human protein protein interaction network. RNA, 13, 1402-1408. (Pubitemid 47347411)
21. Loging W, Harland L, Williams-Jones B. (2007). High-throughput electronic biology: mining information for drug discovery. Nat Rev Drug Discov, 6, 220-230. (Pubitemid 46344626)
22. Màayan A, Jenkins SL, Goldfarb J, Iyengar R. (2007). Network analysis of FDA approved drugs and their targets. Mt Sinai J Med, 74, 27-32. (Pubitemid 46957753)
23. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. (2007). miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res, 35, D149-D155. (Pubitemid 46056188)
24. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P, Shivakumar K, Anuradha N, Reddy R, Raghavan TM, Menon S, Hanumanthu G, Gupta M, Upendran S, Gupta S, Mahesh M, Jacob B, Mathew P, Chatterjee P, Arun KS, Sharma S, Chandrika KN, Deshpande N, Palvankar K, Raghavnath R, Krishnakanth R, Karathia H, Rekha B, Nayak R, Vishnupriya G, Kumar HG, Nagini M, Kumar GS, Jose R, Deepthi P, Mohan SS, Gandhi TK, Harsha HC, Deshpande KS, Sarker M, Prasad TS, Pandey A. (2006). Human protein reference database-2006 update. Nucleic Acids Res, 34, D411-D414.
25. Nacher JC, Schwartz JM. (2008). A global view of drug-therapy interactions. BMC Pharmacol, 8, 5.
26. Overington JP, Al-Lazikani B, Hopkins AL. (2006). How many drug targets are there? Nat Rev Drug Discov, 5, 993-996. (Pubitemid 44835126)
27. Sakharkar MK, Li P, Zhong Z, Sakharkar KR. (2008). Quantitative analysis on the characteristics of targets with FDA approved drugs. Int J Biol Sci, 4, 15-22.
28. Sharan R, Ulitsky I, Shamir R. (2007). Network-based prediction of protein function. Mol Syst Biol, 3, 88.
29. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. (2006). BioGRID: a general repository for interaction datasets. Nucleic Acids Res, 34, D535-D539.
30. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE. (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell, 122, 957-968. (Pubitemid 41345212)
31. Wang YY. (2009). Functional homogeneity in microRNA target heterogeneity. Genome Biol, submitted.
32. Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, Kato H, Hirsch FR, Franklin WA. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol, 19, 1053-1059. (Pubitemid 351796329)
33. Wienholds E, Plasterk RH. (2005). MicroRNA function in animal development. FEBS Lett, 579, 5911-5922. (Pubitemid 41487106)
34. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res, 36, D901-D906. (Pubitemid 351149842)
35. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res, 34, D668-D672.
36. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. (2007). Drugtarget network. Nat Biotechnol, 25, 1119-1126.
37. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. (2007). The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol, 3, e59.
38. Zhu M, Gao L, Li X, Liu Z, Xu C, Yan Y, Walker E, Jiang W, Su B, Chen X, Lin H. (2009). The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target, 17, 524-532.